“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
Thank your Representatives and Senators for Supporting the DOD BCRP Thanks to your advocacy efforts 199 Representatives signed the letter to the House Defense […]
FY2021 Department of Defense Breast Cancer Research Program (DOD BCRP) Letter Thank you to all the NBCC advocates for your […]
Deadline for Letter Signing: Tuesday, March 10 We need our grassroots to take immediate action on our #1 Priority—the Department […]
Meet NBCC’s New Chief Operating Officer, Kristin Walega Kristin Walega joined NBCC as Chief Operating Officer in November. Kristin is […]
Contact your Senators and ask them to sign the FY2021 DOD Breast Cancer Research Program Letter today! The deadline for signing on to […]
